$HHS

HARTE HANKS INC

Insider trades
3
0
1

No SEC Form 4 filings for $HHS in the last 30 days.

See all $HHS insider activity →
Med

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

Ademi LLP says it is investigating Harte Hanks (NASDAQ: HHS) over potential fiduciary duty breaches related to its announced transaction with Star Equity. The deal would pay shareholders $5.00 per share, valuing equity at about $38.4 million, while insiders may receive change-of-control benefits. Ademi alleges the agreement limits competing bids via penalties.

Harte Hanks To Be Acquired By Star Equity For $38.4 Mln

Harte Hanks (HHS) and Star Equity Holdings (STRR) announced a merger in which Star Equity will acquire Harte Hanks for $5 per share, totaling about $38.4 million, about a 100% premium to Harte Hanks’ unaffected price, according to the companies. A 30-day go-shop runs until Sept. 13, with closing expected in 60 to 90 days. HHS was up 3.91% to $2.920 premarket.

HHS sentiment & insider activity

Over the past 7 days, alphai's AI scored 4 news stories mentioning HHS (HARTE HANKS INC). Coverage has skewed bullish: 3 bullish, 0 neutral, and 1 bearish.

Recent HHS coverage spans mergers & acquisitions and financial news.

What's driving HHS

  • The article is a shareholder-litigation solicitation alleging the deal terms are not a fair price and may improperly deter competing bids.

    prnewswire.com · Aug 14, 2026

  • Deal terms and timeline create a takeover-arb setup for HHS, with spread sensitivity to go-shop outcomes and closing probability.

    rttnews.com · Aug 14, 2026

  • Deal terms set a clear takeout value and election mechanics, likely driving spread, liquidity, and arb positioning in HHS.

    finanznachrichten.de · Aug 14, 2026

  • Deal terms and timing create a near-term catalyst for spread trading and risk management around shareholder votes and financing conditions.

    investing.com · Aug 14, 2026

  • Harte Hanks, Inc. reported a narrowed net loss of $392,000 in Q1 2026, with revenue from the Revenue Solutions segment reaching $7.92 million. The company's liquidity remains healthy with $8.98 million in cash. Despite ongoing losses, the company shows signs of stabilization, but profitability remains uncertain.

    Minichart · May 16, 2026

alphai scores every news story that mentions HHS with an AI model for sentiment and relevance, and aggregates insider trades from HARTE HANKS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HHS

Score
$HHSMed

Shareholder Alert: Ademi LLP investigates whether Harte Hanks, Inc. is obtaining a Fair Price for Public Shareholders

Ademi LLP says it is investigating Harte Hanks (NASDAQ: HHS) over potential fiduciary duty breaches related to its announced transaction with Star Equity. The deal would pay shareholders $5.00 per share, valuing equity at about $38.4 million, while insiders may receive change-of-control benefits. Ademi alleges the agreement limits competing bids via penalties.

$HHSHighAI 9/10

Harte Hanks To Be Acquired By Star Equity For $38.4 Mln

Harte Hanks (HHS) and Star Equity Holdings (STRR) announced a merger in which Star Equity will acquire Harte Hanks for $5 per share, totaling about $38.4 million, about a 100% premium to Harte Hanks’ unaffected price, according to the companies. A 30-day go-shop runs until Sept. 13, with closing expected in 60 to 90 days. HHS was up 3.91% to $2.920 premarket.

$HHSHighAI 10/10

Harte Hanks, Inc.: Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

Harte Hanks (NASDAQ:HHS) and Star Equity Holdings (NASDAQ:STRR) entered a definitive merger agreement under which Star Equity will acquire all Harte Hanks shares for $5.00 per share, about $38.4 million total equity value. Consideration is 50% cash and 50% Star Equity 10% preferred stock. Closing is expected in 60 to 90 days.

$HHSHighAI 9/10

Harte Hanks stock rises on $5 per share acquisition deal

Harte Hanks Inc (NASDAQ:HHS) shares rose 2.1% premarket after Star Equity Holdings Inc (NASDAQ:STRR) agreed to acquire HHS for $5.00 per share. The deal implies about $38.4M aggregate equity value, a 100% premium. HHS shareholders may take $5 cash or 0.50 shares of STRRP preferred. Board approved; expected close in 60-90 days.

$HHSLow

Harte Hanks, Inc. Q1 2026 Financial Report: Revenue, Segment Performance, and Accounting Policies Overview

Harte Hanks, Inc. (NASDAQ: HHS) has released its Q1 2026 financial results, reporting a narrowed net loss of $392,000 compared to Q1 2025, though EPS showed a deeper loss. The Revenue Solutions segment generated $7.92 million, highlighting its importance as the primary revenue driver, while the company maintains a healthy liquidity position with $8.98 million in cash. Investors are advised to monitor the company's path to profitability and segment performance due to ongoing losses and slight equity erosion.

$HHSMed

Harte Hanks (HHS) Q2 Revenue Falls 14%

Harte Hanks ( NASDAQ:HHS ) , a marketing and customer experience solutions provider, released its results on August 7, 2025. The most important news from the release was a broad drop in GAAP revenues and profitability, with revenue ( GAAP ) and EBITDA declining sharply across all business ...

Related tickers